Información del producto
LAS101057 is a drug candidate that inhibits the enzyme HMG-CoA reductase, which is responsible for the production of cholesterol in the liver. LAS101057 has been shown to have potential therapeutic effects on symptoms associated with insulin resistance and hyperresponsiveness in animal models. This drug has also been shown to reduce inflammation and increase adenosine levels in human fibroblasts. LAS101057 is currently being studied as a treatment for Alzheimer's disease and anxiety disorders. This drug also blocks the A2A receptor and reduces neuronal death after brain injury, suggesting it may be used to treat strokes.
Propiedades químicas
Consulta técnica sobre: 3D-AMB67648 LAS101057
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
